{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T18:21:53Z","timestamp":1699294913745},"reference-count":0,"publisher":"American Chemical Society (ACS)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[1975,11]]},"DOI":"10.1021\/jm00245a021","type":"journal-article","created":{"date-parts":[[2005,3,18]],"date-time":"2005-03-18T09:37:56Z","timestamp":1111138676000},"page":"1145-1147","source":"Crossref","is-referenced-by-count":12,"title":["2-(3,4-Dichloroanilino)quinolizinium bromide, a unique antispasmodic, antisecretory, and antiulcerogenic agent"],"prefix":"10.1021","volume":"18","author":[{"given":"Robert J.","family":"Alaimo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvin M.","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2002,5,1]]},"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/jm00245a021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T05:51:00Z","timestamp":1680846660000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/jm00245a021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1975,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1975,11]]}},"alternative-id":["10.1021\/jm00245a021"],"URL":"https:\/\/doi.org\/10.1021\/jm00245a021","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[1975,11]]}}}